Cardiovascular — Reportable segment operating profit
Medtronic Cardiovascular — Reportable segment operating profit increased by 2.5% to $899.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.4%, from $1.21B to $899.00M. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Reportable segment operating profit shows a downward trend with a -6.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher profit indicates strong demand, effective pricing power, and efficient cost management within the cardiovascular portfolio.
Detailed definition
This metric represents the operating income generated by the cardiovascular segment after deducting direct operating exp...
Peer comparison
Comparable to segment operating income reported by major medical device competitors in the cardiovascular space.
mdt_segment_cardiovascular_reportable_segment_operating_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26B | $1.16B | $1.10B | $1.08B | $926.00M | $956.00M | $1.05B | $1.03B | $1.17B | $1.09B | $1.12B | $1.09B | $1.20B | $1.13B | $1.16B | $1.21B | $500.00M | $828.00M | $877.00M | $899.00M |
| QoQ Change | — | -8.0% | -5.7% | -1.6% | -14.0% | +3.2% | +9.5% | -1.2% | +13.5% | -7.0% | +2.3% | -2.4% | +10.0% | -6.2% | +3.5% | +3.5% | -58.5% | +65.6% | +5.9% | +2.5% |
| YoY Change | — | — | — | — | -26.6% | -17.7% | -4.4% | -4.0% | +26.8% | +14.2% | +6.7% | +5.4% | +2.1% | +3.0% | +4.2% | +10.6% | -58.3% | -26.4% | -24.7% | -25.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's cardiovascular — reportable segment operating profit?
- Medtronic (MDT) reported cardiovascular — reportable segment operating profit of $899.00M in Q1 2026.
- How has Medtronic's cardiovascular — reportable segment operating profit changed year-over-year?
- Medtronic's cardiovascular — reportable segment operating profit decreased by 25.4% year-over-year, from $1.21B to $899.00M.
- What is the long-term trend for Medtronic's cardiovascular — reportable segment operating profit?
- Over 4 years (2021 to 2025), Medtronic's cardiovascular — reportable segment operating profit has grown at a -6.8% compound annual growth rate (CAGR), from $4.51B to $3.41B.
- What does cardiovascular — reportable segment operating profit mean?
- The profit earned by the cardiovascular segment from its core business operations.